You are here
BOSTON BIOTECHNOLOGY CORPORATION
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
GHRELIN VACCINES FOR CONTROLLING OBESITY
Amount: $749,874.00DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the United States and adversely affects the health of both adults and children. While dieting and exercise have had lit ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
GHRELIN VACCINES FOR CONTROLLING OBESITY
Amount: $74,098.00DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the United States and adversely affects the health of both adults and children. While dieting and exercise have had lit ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE
Amount: $749,874.00DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...
SBIRPhase II2004Department of Health and Human Services National Institutes of Health -
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE
Amount: $100,000.00DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
HTS for Protein Splicing Inhibitors as TB Drugs
Amount: $297,643.00DESCRIPTION (provided by applicant): One-third of the world' s population (2 billion people) are infected with Mycobacterium tuberculosis and 5-10% of these suffer active tuberculosis, leading to nea ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
N/A
Amount: $0.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $378,083.00N/A
SBIRPhase II2000Department of Health and Human Services National Institutes of Health -
IMMUNOTHERAPY OF ALZHEIMERS DISEASE
Amount: $99,489.00N/A
SBIRPhase I1998Department of Health and Human Services -
CATALYTIC ANTIBODIES FOR THE TREATMENT OF AIDS
Amount: $99,911.00N/A
SBIRPhase I1996Department of Health and Human Services -
SUPERACTIVE B-GALACTOSIDASE FOR ENZYME IMMUNOASSAY
Amount: $50,000.00IN DIAGNOSTIC ENZYME IMMUNOASSAYS (EIA'S), ENZYMES ARE CONJUGATED WITH EITHER ANTIGEN OR ANTIBODY TO AMPLIFY THE PRESENCE OF ANTIGEN-ANTIBODY COMPLEXES. CURRENTLY, BETA-GALACTOSIDASE, HORSERADISH PERO ...
SBIRPhase I1989Department of Health and Human Services
